Publications: Prof Jude Fitzgibbon
Lin WY, Fordham SE, Hungate E, Sunter NJ, Elstob C, Xu Y, Park C, Quante A et al.
(
2022
)
.
Author Correction: Genome-wide association study identifies susceptibility loci for acute myeloid leukemia (Nature Communications, (2021), 12, 1, (6233), 10.1038/s41467-021-26551-x)
.
Nature Communications
vol.
13
,
(
1
)
Hug N, Aitken S, Longman D, Raab M, Armes H, Mann AR, Rio-Machin A, Fitzgibbon J et al.
(
2022
)
.
A dual role for the RNA helicase DHX34 in NMD and pre-mRNA splicing and its function in hematopoietic differentiation
.
RNA
vol.
28
,
(
9
)
1224
-
1238
.
Rio‐Machin A, Fitzgibbon J
(
2022
)
.
DDX41: the poster child for familial AML
.
Blood
vol.
140
,
(
7
)
667
-
669
.
Grey W, Rio-Machin A, Casado P, Grönroos E, Ali S, Miettinen JJ, Bewicke-Copley F, Parsons A et al.
(
2022
)
.
CKS1 inhibition depletes leukemic stem cells and protects healthy hematopoietic stem cells in acute myeloid leukemia
.
Science Translational Medicine
vol.
14
,
(
650
)
Armes H, Rio-Machin A, Krizsán S, Bödör C, Kaya F, Bewicke-Copley F, Alnajar J, Walne A et al.
(
2022
)
.
Acquired somatic variants in inherited myeloid malignancies
.
Leukemia
vol.
36
,
(
5
)
1377
-
1381
.
Armes H, Bewicke-Copley F, Rio-Machin A, Di Bella D, Philippe C, Wozniak A, Tummala H, Wang J et al.
(
2022
)
.
Germline ERCC excision repair 6 like 2 (ERCC6L2) mutations lead to impaired erythropoiesis and reshaping of the bone marrow microenvironment
.
British Journal of Haematology
Gerdes H, Casado P, Dokal A, Hijazi M, Akhtar N, Osuntola R, Rajeeve V, Fitzgibbon J et al.
(
2021
)
.
Drug ranking using machine learning systematically predicts the efficacy of anti-cancer drugs
.
Nature Communications
vol.
12
,
(
1
)
Lin WY, Fordham SE, Hungate E, Sunter NJ, Elstob C, Xu Y, Park C, Quante A et al.
(
2021
)
.
Genome-wide association study identifies susceptibility loci for acute myeloid leukemia
.
Nature Communications
vol.
12
,
(
1
)
Homan CC, King-Smith SL, Lawrence DM, Arts P, Feng J, Andrews J, Armstrong M, Ha T et al.
(
2021
)
.
The RUNX1 database (RUNX1db): Establishment of an expert curated RUNX1 registry and genomics database as a public resource for familial platelet disorder with myeloid malignancy
.
Haematologica
vol.
106
,
(
11
)
3004
-
3007
.
Heward J, Konali L, D'Avola A, Close K, Yeomans A, Philpott M, Dunford J, Rahim T et al.
(
2021
)
.
KDM5 inhibition offers a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas
.
Blood
vol.
138
,
(
5
)
370
-
381
.
Rio-Machin A, Fitzgibbon J
(
2021
)
.
Germline ETV6 variants: not ALL created equally
.
Blood
vol.
137
,
(
3
)
288
-
289
.
Maybury BD, Saavedra-Torres Y, Snoeks TJA, Fitzgibbon J, Calado DP
(
2021
)
.
Generation and Surgical Analysis of Genetic Mouse Models to Study NF-κB-Driven Pathogenesis of Diffuse Large B Cell Lymphoma
.
vol.
2366
,
321
-
342
.
Fitzgibbon J, Weigert O
(
2021
)
.
Molecular genetics in indolent lymphomas
.
Hematologic Malignancies
,
Fitzgibbon J
(
2020
)
.
Inherited Myeloid Malignancies
.
EUROPEAN JOURNAL OF HUMAN GENETICS
.
vol.
28
,
17
-
17
.
Rio-Machin A, Vulliamy T, Hug N, Walne A, Tawana K, Cardoso S, Ellison A, Pontikos N et al.
(
2020
)
.
The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants
.
Nature Communications
vol.
11
,
(
1
)
Rio-Machin A, Casado-Izquierdo P, Miettinen J, Bewicke-Copley F, Khan N, Demeulemeester J, Krizsán S, Zheng J et al.
(
2020
)
.
Integration of Deep Multi-Omics Profiling Veals New Insights into the Biology of Poor-Risk Acute Myeloid Leukemia
.
Blood
vol.
136
,
(
Supplement 1
)
39
-
40
.
Uyulur F, Bewicke-Copley F, Anene CA, Schlesner M, MMML-Seq Project I, Siebert R, Okosun J, Fitzgibbon J et al.
(
2020
)
.
Systematic Evaluation of Somatic Cis -Regulatory Mutations in Follicular Lymphoma
.
Blood
vol.
136
,
(
Supplement 1
)
26
-
27
.
Larrea E, Fernandez‐mercado M, Guerra‐assunção JA, Wang J, Goicoechea I, Gaafar A, Ceberio I, Lobo C et al.
(
2020
)
.
Identification of recurrent mutations in the microrna‐binding sites of b‐cell lymphoma‐ associated genes in follicular lymphoma
.
International Journal of Molecular Sciences
vol.
21
,
(
22
)
1
-
12
.
Kumar EA, Okosun J, Fitzgibbon J
(
2020
)
.
The Biological Basis of Histologic Transformation
.
Hematology/Oncology Clinics of North America
vol.
34
,
(
4
)
771
-
784
.
Dokal I, Tummala H, Vulliamy T, Walne A
(
2020
)
.
A frameshift variant in the specificity protein 1 triggers superactivation of SP1-mediated transcription in familial bone marrow failure
.
Proceedings of the National Academy of Sciences of USA
Article
32636268
,
Fitzgibbon J, Park S, Cook G, Paiva B, Gloghini A, Van Breda E, Busti F, Garderet L et al.
(
2020
)
.
Recent Advancements in Hematology: Knowledge, Methods and Dissemination, Part 1
.
Hemato
vol.
1
,
(
1
)
Araf S, Korfi K, Bewicke-Copley F, Wang J, Cogliatti S, Kumar E, Forrer F, Barrington SF et al.
(
2020
)
.
Genetic heterogeneity highlighted by differential FDG-PET response in diffuse large B-cell lymphoma
.
Haematologica
vol.
105
,
(
6
)
E318
-
E321
.
Waclawiczek A, Hamilton A, Rouault-Pierre K, Abarrategi A, Albornoz MG, Miraki-Moud F, Bah N, Gribben J et al.
(
2020
)
.
Mesenchymal niche remodeling impairs hematopoiesis via stanniocalcin 1 in acute myeloid leukemia
.
Journal of Clinical Investigation
vol.
130
,
(
6
)
3038
-
3050
.
Cucco F, Barrans S, Sha C, Clipson A, Crouch S, Dobson R, Chen Z, Thompson JS et al.
(
2020
)
.
Distinct genetic changes reveal evolutionary history and heterogeneous molecular grade of DLBCL with MYC/BCL2 double-hit
.
Leukemia
vol.
34
,
(
5
)
1329
-
1341
.
Maybury B, Fitzgibbon J, Calado D
(
2020
)
.
An immunocompetent, spontaneous mouse model of DLBCL for studying the response to R-CHOP and identifying new treatment targets
.
BRITISH JOURNAL OF HAEMATOLOGY
.
vol.
189
,
110
-
111
.
Fitzgibbon J, Busca A, Gloghini A, López-Guillermo A, Orazi A, Carlo-Stella C, Andrès E, Van Breda E et al.
(
2020
)
.
Recent Advancements in Hematology: Knowledge, Methods and Dissemination
.
Hemato
vol.
1
,
(
1
)
5
-
6
.
Charrot S, Armes H, Rio-Machin A, Fitzgibbon J
(
2020
)
.
AML through the prism of molecular genetics
.
British Journal of Haematology
vol.
188
,
(
1
)
49
-
62
.
Carbone A, Roulland S, Gloghini A, Younes A, von Keudell G, López-Guillermo A, Fitzgibbon J
(
2019
)
.
Follicular lymphoma
.
Nature Reviews Disease Primers
vol.
5
,
(
1
)
Jurinovic V, Passerini V, Oestergaard MZ, Knapp A, Mundt K, Araf S, Richter J, Fitzgibbon J et al.
(
2019
)
.
Evaluation of the m7-FLIPI in Patients with Follicular Lymphoma Treated within the Gallium Trial: EZH2 mutation Status May be a Predictive Marker for Differential Efficacy of Chemotherapy
.
Blood
.
vol.
134
,
122
-
122
.
Bewicke-Copley F, Korfi K, Araf S, Kumar EA, Cummin TEC, Ashton-Key M, Barrans S, Van Hoppe S et al.
(
2019
)
.
Longitudinal Analyses of Diagnostic-Relapse Biopsies of Diffuse Large B Cell Lymphoma Reveal a Poor Risk Subset of ABC Patients Based on the Expression of a 30 Gene Panel
.
Blood
vol.
134
,
(
Supplement_1
)
2769
-
2769
.
Ortega-Molina A, Deleyto-Seldas N, Carreras J, Sanz A, Lebrero-Fernández C, Menéndez C, Vandenberg A, Fernández-Ruiz B et al.
(
2019
)
.
Oncogenic Rag GTPase signalling enhances B cell activation and drives follicular lymphoma sensitive to pharmacological inhibition of mTOR
.
Nature Metabolism
vol.
1
,
(
8
)
775
-
789
.
Okosun J, Bödör C, Batlevi C, Nagy N, Michot J, Schneider T, Alizadeh H, Simon Z et al.
(
2019
)
.
EZH2 GAIN‐OF‐FUNCTION MUTATIONS ARE NOT ASSOCIATED WITH MORE FAVORABLE PROGNOSIS IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (FL): A PRELIMINARY ANALYSIS ON 590 PATIENTS
.
Hematological Oncology
vol.
37
,
192
-
193
.
Korfi K, Araf S, Bewicke‐Copley F, Kumar E, Cummin T, Ashton‐Key M, Barrans S, Van Hoppe S et al.
(
2019
)
.
LONGITUDINAL ANALYSES OF DIAGNOSTIC‐RELAPSE BIOPSIES OF DIFFUSE LARGE B CELL LYMPHOMA SUGGEST THAT RELAPSE IS MEDIATED BY DISTINCT MECHANISMS IN ABC AND GCB LYMPHOMA
.
Hematological Oncology
vol.
37
,
142
-
143
.
Araf S, Wang J, Korfi K, Pangault C, Kotsiou E, Rio-Machin A, Rahim T, Heward J et al.
(
2019
)
.
Correction: Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma (Leukemia, (2018), 32, 5, (1261-1265), 10.1038/s41375-018-0043-y)
.
Leukemia
vol.
33
,
(
6
)
Kumar E, Korfi K, Bewicke-Copley F, Witzig T, Leukam M, Ansell S, Scott J, Rallis K et al.
(
2019
)
.
MUTATIONS AFFECTING THE CREBBP HAT DOMAIN PREDICT RESPONSE TO MTOR INHIBITORS EVEROLIMUS AND TEMSIROLIMUS IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA
.
HemaSphere
vol.
3
,
Rio-Machin A, Vulliamy T, Hug N, Caceres JF, Fitzgibbon J, Dokal I
(
2019
)
.
PF213 THE GENETIC LANDSCAPE OF FAMILIAL MDS/AML; RECURRING MUTATIONS IN THE RNA HELICASE DHX34 LEADING TO DEFECTS IN NONSENSE-MEDIATED RNA DECAY
.
HemaSphere
vol.
3
,
(
S1
)
Kumar E, Korfi K, Bewicke-Copley F, Witzig T, Leukam M, Ansell S, Scott J, Rallis K et al.
(
2019
)
.
PF513 MUTATIONS AFFECTING THE CREBBP HAT DOMAIN PREDICT RESPONSE TO MTOR INHIBITORS EVEROLIMUS AND TEMSIROLIMUS IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA
.
HemaSphere
vol.
3
,
(
S1
)
Bödör C, Batlevi C, Nagy N, Michot J-M, Schneider T, Alizadeh H, Simon Z, Vose J et al.
(
2019
)
.
PS1247 EZH2 GAIN-OF-FUNCTION MUTATIONS ARE NOT ASSOCIATED WITH MORE FAVORABLE PROGNOSIS IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: A PRELIMINARY ANALYSIS ON 590 PATIENTS
.
HemaSphere
vol.
3
,
(
S1
)
568
-
569
.
Heward J, Koniali L, D’Avola A, Close K, Yeomans A, Johnson P, Okosun J, Neve R et al.
(
2019
)
.
S844 KDM5 INHIBITION OFFERS A NOVEL THERAPEUTIC STRATEGY FOR THE TREATMENT OF KMT2D MUTANT LYMPHOMAS
.
HemaSphere
vol.
3
,
(
S1
)
376
-
377
.
Araf S, Wang J, Ashton-Key M, Korfi K, Di Bella D, Rio-Machin A, Odabashian M, Foria V et al.
(
2019
)
.
Transmission of diffuse large B-cell lymphoma by an allogeneic stem-cell transplant
.
Haematologica
vol.
104
,
(
4
)
e174
-
e177
.
Merron B, Kazmi-Stokes S, Cummin T, Barrans S, Araf S, Korfi K, Pascua LDL, Caddy J et al.
(
2019
)
.
Precision medicine for patients with lymphoma; the Bloodwise Precision Medicine for Aggressive Lymphomas (PMAL) consortium
.
Clinical Medicine
vol.
19
,
(
Suppl 2
)
100
-
101
.
Jakobsen JS, Laursen LG, Schuster MB, Pundhir S, Schoof E, Ge Y, D'Altri T, Vitting-Seerup K et al.
(
2019
)
.
Mutant CEBPA directly drives the expression of the targetable tumor-promoting factor CD73 in AML
.
Science Advances
vol.
5
,
(
7
)
Brown AL, Armstrong M, Lawrence D, Wang P, Arts P, Duployez N, Churpek J, Tawana K et al.
(
2018
)
.
Development of a Data Portal for Aggregation and Analysis of Genomics Data in Familial Platelet Disorder with Predisposition to Myeloid Malignancy - the RUNX1.DB
.
Blood
vol.
132
,
(
Supplement 1
)
5241
-
5241
.
DOKAL I, TUMMALA H, VULLIAMY T
(
2018
)
.
homozygous OB-fold variants in telomere protein TPP1 are associated with dyskeratosis congenita-like phenotypes
.
Blood
vol.
132
,
1349
-
1353
.
Casado P, Wilkes EH, Miraki-Moud F, Hadi MM, Rio-Machin A, Rajeeve V, Pike R, Iqbal S et al.
(
2018
)
.
Proteomic and genomic integration identifies kinase and differentiation determinants of kinase inhibitor sensitivity in leukemia cells
.
Leukemia
vol.
32
,
(
8
)
1818
-
1822
.
Okosun J, Kridel R, Fitzgibbon J
(
2018
)
.
Rituximab as a first step in tackling transformation
.
The Lancet Haematology
vol.
5
,
(
8
)
e326
-
e327
.
Heward JA, Kumar EA, Korfi K, Okosun J, Fitzgibbon J
(
2018
)
.
Precision medicine and lymphoma
.
Curr Opin Hematol
vol.
25
,
(
4
)
329
-
334
.
Araf S, Wang J, Korfi K, Pangault C, Kotsiou E, Rio-Machin A, Rahim T, Heward J et al.
(
2018
)
.
Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma
.
Leukemia
vol.
32
,
(
5
)
1258
-
1263
.
Al Seraihi AF, Rio-Machin A, Tawana K, Bödör C, Wang J, Nagano A, Heward JA, Iqbal S et al.
(
2018
)
.
GATA2 monoallelic expression underlies reduced penetrance in inherited GATA2-mutated MDS/AML
.
Leukemia
vol.
32
,
(
11
)
2502
-
2507
.
Araf S, Okosun J, Fitzgibbon J
(
2018
)
.
Predicting early relapse in follicular lymphoma: have we turned a corner?
.
The Lancet Oncology
vol.
19
,
(
4
)
441
-
442
.
Casado P, Wilkes EH, Miraki-Moud F, Hadi MM, Rio-Machin A, Rajeeve V, Pike R, Iqbal S et al.
(
2017
)
.
Proteomic and genomic integration identifies kinase and differentiation determinants of kinase inhibitor sensitivity in leukemia cells
.
Leukemia
Araf S, Wang J, Korfi K, Pangault C, Kotsiou E, Rio-Machin A, Rahim T, Heward JA et al.
(
2017
)
.
Genomic Profiling Reveals Spatial Intra-Tumor Heterogeneity in Follicular Lymphoma
.
BLOOD
.
vol.
130
,
Araf S, Korfi K, Nagano A, Cummin TEC, Bentley M, Thorner AR, Ashton-Key M, Calaminici M et al.
(
2017
)
.
Longitudinal Analyses of the Genomic, Transcriptomic, and T Cell Repertoire in Diffuse Large B Cell Lymphoma Demonstrates Changes in Signaling and Immune Recognition at Relapse
.
BLOOD
.
vol.
130
,
Gascoyne RD, Nadel B, Pasqualucci L, Fitzgibbon J, Payton JE, Melnick A, Weigert O, Tarte K et al.
(
2017
)
.
Follicular lymphoma: State-of-the-art ICML workshop in Lugano 2015
.
Hematological Oncology
vol.
35
,
(
4
)
397
-
407
.
Horton SJ, Giotopoulos G, Yun H, Vohra S, Sheppard O, Bashford-Rogers R, Rashid M, Clipson A et al.
(
2017
)
.
Early loss of Crebbp confers malignant stem cell properties on lymphoid progenitors
.
Nature Cell Biology
.
vol.
19
,
1093
-
1104
.
Rio-Machin A, Gómez-López G, Muñoz J, Garcia-Martinez F, Maiques-Diaz A, Alvarez S, Salgado RN, Shrestha M et al.
(
2017
)
.
The molecular pathogenesis of the NUP98-HOXA9 fusion protein in acute myeloid leukemia
.
Leukemia
vol.
31
,
(
9
)
2000
-
2005
.
Tawana K, Wang J, Király PA, Kállay K, Benyó G, Zombori M, Csomor J, Al Seraihi A et al.
(
2017
)
.
Recurrent somatic JAK-STAT pathway variants within a RUNX1-mutated pedigree
.
European Journal of Human Genetics
vol.
25
,
(
8
)
1020
-
1024
.
Cummin TE, Araf S, Du M, Barrans S, Bentley MA, Clipson A, Wang M, Ahmed S et al.
(
2017
)
.
PROGNOSTIC SIGNIFICANCE AND CORRELATION TO GENE EXPRESSION PROFILE OF EZH2 MUTATIONS IN DIFFUSE LARGE B‐CELL LYMPHOMA (DLBL) IN 2 LARGE PROSPECTIVE STUDIES
.
Hematological Oncology
vol.
35
,
(
S2
)
158
-
159
.
Tawana K, Rio-Machin A, Preudhomme C, Fitzgibbon J
(
2017
)
.
Familial CEBPA-mutated acute myeloid leukemia
.
Seminars in Hematology
vol.
54
,
(
2
)
87
-
93
.
Korfi K, Ali S, Heward JA, Fitzgibbon J
(
2017
)
.
Follicular lymphoma, a B cell malignancy addicted to epigenetic mutations
.
Epigenetics
vol.
12
,
(
5
)
370
-
377
.
Casado P, Wilkes E, Hadi MM, Rajeeve V, Miraki-Moud F, Pike R, Del Rio-Machin A, Iqbal S et al.
(
2016
)
.
Differentiation Status Revealed By Shotgun Phosphoproteomics Determines Sensitivity of Primary AML Cells to Kinase Inhibitors
.
Blood
.
vol.
128
,
840
-
840
.
Fitzgibbon J
(
2016
)
.
Genomic Discovery, Prognosis, and Target Therapy Development
.
Blood
vol.
128
,
(
22
)
Rio-Machin A, Gomez-Lopez G, Maiques-Diaz A, Alvarez S, Calasanz MJ, Fitzgibbon J, Cigudosa JC
(
2016
)
.
HDAC Inhibitors As Novel Targeted Therapies for NUP98-HOXA9 AML Patients
.
Blood
.
vol.
128
,
2685
-
2685
.
Noerenberg D, Mansouri L, Young E, Mareike F, Abdulla M, Asmar F, Gonzalez-Farre B, Anna T et al.
(
2016
)
.
NFKBIE Deletions: A Novel Marker of Clinical Aggressiveness in Primary Mediastinal B-Cell Lymphoma
.
BLOOD
.
vol.
128
,
Britton DJ, Wilkes E, Casado P, Rajeeve V, Fitzgibbon J, Gribben J, Cutillas PR
(
2016
)
.
Proteomic Analysis Directs Effective Drug Selection in Relapsed AML By Quantifying Drug Targets
.
Blood
.
vol.
128
,
5265
-
5265
.
Al Seraihi A, Rio-Machin A, Tawana K, Bödör C, Araf S, Heward JA, Smith M, Iqbal S et al.
(
2016
)
.
Variable Penetrance Is Linked with Monoallelic Gene Expression in Inherited GATA2-Mutated MDS/AML
.
Blood
.
vol.
128
,
3916
-
3916
.
Noerenberg* D, Mansouri* L, Young E, Mareike F, Abdulla M, Asmar F, Gonzalez-Farre B, Anna T et al.
(
2016
)
.
ΝFΚΒΙΕ Deletions: A Novel Marker of Clinical Aggressiveness in Primary Mediastinal B-Cell Lymphoma
.
Blood
vol.
128
,
(
22
)
609
-
609
.
Stunnenberg HG, Abrignani S, Adams D, de Almeida M, Altucci L, Amin V, Amit I, Antonarakis SE et al.
(
2016
)
.
The International Human Epigenome Consortium: A Blueprint for Scientific Collaboration and Discovery
.
Cell
vol.
167
,
(
5
)
1145
-
1149
.
Mansouri L, Noerenberg D, Young E, Mylonas E, Abdulla M, Frick M, Asmar F, Ljungström V et al.
(
2016
)
.
Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma
.
Blood
vol.
128
,
(
23
)
2666
-
2670
.
Araf S, Korfi K, Rahim T, Davies A, Fitzgibbon J
(
2016
)
.
Advances in the molecular diagnosis of diffuse large B-cell lymphoma in the era of precision medicine
.
Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare
vol.
16
,
(
10
)
1093
-
1102
.
Araf S, Fitzgibbon J
(
2016
)
.
Pediatric-type FL: Simply different
.
Blood
vol.
128
,
(
8
)
1030
-
1031
.
Ripperger T, Tawana K, Kratz C, Schlegelberger B, Fitzgibbon J, Steinemann D
(
2016
)
.
Clinical utility gene card for: Familial platelet disorder with associated myeloid malignancies
.
European Journal of Human Genetics
vol.
24
,
(
8
)
e1
-
e4
.
Tummala H, Walne AJ, Williams M, Bockett N, Collopy L, Cardoso S, Ellison A, Wynn R et al.
(
2016
)
.
DNAJC21 Mutations Link a Cancer-Prone Bone Marrow Failure Syndrome to Corruption in 60S Ribosome Subunit Maturation
.
American Journal of Human Genetics
vol.
99
,
(
1
)
115
-
124
.
Larrea E, Fernandez-Mercado M, Ceberio I, Guerra-Assunção JA, Okosun J, Fitzgibbon J, Lawrie C
(
2016
)
.
110 Follicular lymphoma cases harbour recurrent mutations in micro-RNA binding sites of genes associated with lymphomagenesis
.
European Journal of Cancer
vol.
61
,
s11
-
s12
.
Larrea E, Fernandez-Mercado M, Ceberio I, Guerra-Assuncao JA, Okosun J, Fitzgibbon J, Lawrie C
(
2016
)
.
Follicular lymphoma cases harbour recurrent mutations in microRNA binding sites of genes associated with lymphomagenesis
.
EUROPEAN JOURNAL OF CANCER
.
vol.
61
,
S11
-
S12
.
GROSE RP, Dawkins JBN, Wang J, maniati, heward, koniali, kocher, martin et al.
(
2016
)
.
Reduced expression of histone methyltransferases KMT2C and KMT2D correlates with improved outcome in pancreatic ductal adenocarcinoma
.
Cancer Research
Araf S, Wang J, Pangault C, Kotsiou E, Hoxha E, Iqbal S, Davies J, Johnson P et al.
(
2016
)
.
GENOMIC PROFILING REVEALS SPATIAL HETEROGENEITY IN FOLLICULAR LYMPHOMA: IMPLICATIONS FOR PRECISION MEDICINE
.
HAEMATOLOGICA
.
vol.
101
,
270
-
270
.
Britton D, Casado P, Rajeeve V, Wilkes E, Smith R, Fitzgibbon J, Gribben J, Cutillas P
(
2016
)
.
PROTEOMIC ANALYSIS OF RELAPSE AML IDENTIFIES OPPORTUNITIES FOR THERAPEUTIC INTERVENTION IN INDIVIDUAL PATIENTS
.
HAEMATOLOGICA
.
vol.
101
,
373
-
373
.
Okosun J, Wolfson RL, Wang J, Araf S, Wilkins L, Castellano BM, Escudero-Ibarz L, Al Seraihi AF et al.
(
2016
)
.
Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma (vol 48, pg 183, 2016)
.
NATURE GENETICS
vol.
48
,
(
6
)
700
-
700
.
Rio-Machin A, Cardoso S, Tawana K, Wang J, Chelala C, Plagnol V, Wallis Y, Ryan G et al.
(
2016
)
.
WHOLE EXOME SEQUENCING REVEALS NOVEL CANDIDATE GENES IN FAMILIAL MDS/AML
.
HAEMATOLOGICA
.
vol.
101
,
205
-
206
.
Okosun J, Wolfson RL, Wang J, Araf S, Wilkins L, Castellano BM, Escudero-Ibarz L, Seraihi AFA et al.
(
2016
)
.
Corrigendum: Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma
.
Nat Genet
vol.
48
,
(
6
)
700
-
700
.
DOKAL I
(
2016
)
.
Germline heterozygous DDX41 vriants in a subset of familial myelodysplasia and acute myeloid leukaemia
.
Leukemia
Okosun J, Montoto S, Fitzgibbon J
(
2016
)
.
The routes for transformation of follicular lymphoma
.
Current Opinion in Hematology
vol.
23
,
(
4
)
1
-
1
.
Kotsiou E, Okosun J, Besley C, Iqbal S, Matthews J, Fitzgibbon J, Gribben J, DAVIES JK
(
2016
)
.
TNFRSF14 aberrations in follicular lymphoma increase clinically significant allogeneic T-cell responses
.
Blood
vol.
128
,
(
1
)
72
-
81
.
Strefford JC, Fitzgibbon J, Rose-Zerilli MJJ, Bödör C
(
2016
)
.
The genetics of mature B-cell malignancies
.
The Genetic Basis of Haematological Cancers
,
Tawana K, Fitzgibbon J
(
2016
)
.
Inherited DDX41 mutations: 11 genes and counting
.
Blood
vol.
127
,
(
8
)
960
-
961
.
Klapper W, Klein U, De Silva NS, Zha S, Crowe JL, Dai B, Weilemann A, Okosun J et al.
(
2016
)
.
5. Follicular lymphoma
.
Malignant Lymphomas
,
Okosun J, Wolfson RL, Wang J, Araf S, Wilkins L, Castellano BM, Escudero-Ibarz L, Al Seraihi AF et al.
(
2016
)
.
Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma
.
Nature Genetics
vol.
48
,
(
2
)
183
-
188
.
Engert A, Balduini C, Brand A, Coiffier B, Cordonnier C, Döhner H, De Wit TD, Eichinger S et al.
(
2016
)
.
The european hematology association roadmap for european hematology research: A consensus document
.
Haematologica
vol.
101
,
(
2
)
115
-
208
.
Araf S, Okosun J, Koniali L, Fitzgibbon J, Heward J
(
2016
)
.
Epigenetic dysregulation in follicular lymphoma
.
Epigenomics
vol.
8
,
(
1
)
77
-
84
.
Okosun J, Fitzgibbon J
(
2016
)
.
Follicular lymphoma
.
Malignant Lymphomas: Biology and Molecular Pathogenesis
,
Okosun J, Wolfson RL, Wang J, Araf S, Wilkins L, Castellano BM, Escudero-Ibarz L, Al Seraihi AF et al.
(
2015
)
.
Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma
.
Nature Genetics
.
Tawana K, Wang J, Renneville A, Bödör C, Hills R, Loveday C, Savic A, Van Delft FW et al.
(
2015
)
.
Disease evolution and outcomes in familial AML with germline CEBPA mutations
.
Blood
vol.
126
,
(
10
)
1214
-
1223
.
Carlotti E, Wrench D, Rosignoli G, Marzec J, Sangaralingam A, Hazanov L, Michaeli M, Hallam S et al.
(
2015
)
.
High throughput sequencing analysis of the immunoglobulin heavy chain gene from flow-sorted B cell sub-populations define the dynamics of follicular lymphoma clonal evolution
.
PLoS ONE
vol.
10
,
(
9
)
Tawana K, Wang J, Kiraly PA, Kallay K, Benyo G, Krivan G, Csomor J, Fitzgibbon J et al.
(
2015
)
.
CONVERGENCE OF SOMATIC MUTATIONS WITHIN THE JAK-STAT SIGNALLING PATHWAY IN A NOVEL RUNX1-MUTATED PEDIGREE
.
HAEMATOLOGICA
.
vol.
100
,
9
-
10
.
Koniali L, Heward J, Loveday C, Wilkins L, Ishfaq M, Wang J, Okosun J, Packham G et al.
(
2015
)
.
KDM5 INHIBITION LEADS TO INCREASED H3K4ME3 LEVELS AND CELL DEATH IN GERMINAL CENTRE LYMPHOMA CELL LINES INDEPENDENT OF MLL2 MUTATION STATUS
.
HAEMATOLOGICA
.
vol.
100
,
104
-
104
.
Noerenberg D, Frick M, Couronne L, Lenze D, Baldus CD, Bastard C, Okosun J, Fitzgibbon J et al.
(
2015
)
.
NFKBIE MUTATIONS OCCUR IN 15% OF GCB DLBCL AND IN VARIOUS OTHER LYMPHOID MALIGNANCIES
.
HAEMATOLOGICA
.
vol.
100
,
549
-
549
.
Kotsiou E, Okosun J, Clear AJ, Iqbal S, Fitzgibbon J, Gribben JG, Davies JK
(
2014
)
.
TNFRSF14 aberrations in Follicular Lymphoma B Cells Result in Increased Alloresponses in Vitro and in Vivo
.
Blood
.
vol.
124
,
2426
-
2426
.
Haider S, Wang J, Nagano A, Desai A, Arumugam P, Dumartin L, Fitzgibbon J, Hagemann T et al.
(
2014
)
.
A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma
.
Genome Medicine
vol.
6
,
(
12
)
Rohatiner AZS, Smith ML, Spinelli O, Rambaldi A, Bassan R, di Bona E, Rodeghiero F, Raimondi R et al.
(
2014
)
.
Myeloblative therapy with autologous haematopoietic stem cell support as consolidation of first remission in acute myeloid leukaemia - very long follow-up
.
British Journal of Haematology
vol.
167
,
(
5
)
724
-
726
.
Okosun J, Packham G, Fitzgibbon J
(
2014
)
.
Investigational epigenetically targeted drugs in early phase trials for the treatment of haematological malignancies
.
Expert Opin Investig Drugs
vol.
23
,
(
10
)
1321
-
1332
.
Bouska A, McKeithan TW, Deffenbacher KE, Lachel C, Wright GW, Iqbal J, Smith LM, Zhang W et al.
(
2014
)
.
Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma
.
BLOOD
vol.
123
,
(
11
)
1681
-
1690
.
Okosun J, Bödör C, Wang J, Araf S, Yang CY, Pan C, Boller S, Cittaro D et al.
(
2014
)
.
Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma
.
Nature Genetics
vol.
46
,
(
2
)
176
-
181
.
Okosun J, Bödör C, Wang J, Araf S, Yang C-Y, Pan C, Boller S, Cittaro D et al.
(
2014
)
.
Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma
.
Nat Genet
vol.
46
,
(
2
)
176
-
181
.
Tawana K, Renneville A, Wang J, Georgiades P, Thomas X, Mialou V, Savic A, Van Delft FW et al.
(
2013
)
.
Familial AML With Germline CEBPA Mutations: Extended Clinical Outcomes and Analysis Of Secondary Mutations Using Whole Exome Sequencing
.
Blood
.
vol.
122
,
740
-
740
.
Popov N, Maniati E, Marzec J, Okosun J, Scott R, Kranz A, Stewart F, Chelala C et al.
(
2013
)
.
Investigating The Role Of MLL2 (Mll4) In B Cell Development
.
Blood
.
vol.
122
,
343
-
343
.
Mutsaers PGNJ, van de Loosdrecht AA, Tawana K, Bödör C, Fitzgibbon J, Menko FH
(
2013
)
.
Highly variable clinical manifestations in a large family with a novel GATA2 mutation
.
Leukemia
vol.
27
,
(
11
)
2247
-
2248
.
Bödör C, Grossmann V, Popov N, Okosun J, O'Riain C, Tan K, Marzec J, Araf S et al.
(
2013
)
.
EZH2 mutations are frequent and represent an early event in follicular lymphoma
.
Blood
vol.
122
,
(
18
)
3165
-
3168
.
Gertner-Dardenne J, Fauriat C, Orlanducci F, Thibult M-L, Pastor S, Fitzgibbon J, Bouabdallah R, Xerri L et al.
(
2013
)
.
The co-receptor BTLA negatively regulates human V gamma 9V delta 2 T-cell proliferation: a potential way of immune escape for lymphoma cells
.
BLOOD
vol.
122
,
(
6
)
922
-
931
.
Green CL, Tawana K, Hills RK, Bödör C, Fitzgibbon J, Inglott S, Ancliff P, Burnett AK et al.
(
2013
)
.
GATA2 mutations in sporadic and familial acute myeloid leukaemia patients with CEBPA mutations
.
Br J Haematol
vol.
161
,
(
5
)
701
-
705
.
Okosun J, Clear A, Iqbal S, Matthews J, Gribben J, Fitzgibbon J, Davies J
(
2013
)
.
TNFRSF14 aberrations are associated with death from acute GvHD after reduced-intensity conditioned allogeneic haematopoietic stem cell transplantation for follicular lymphoma
.
BONE MARROW TRANSPLANTATION
.
vol.
48
,
S169
-
S169
.
Robbez-Masson LJ, Bödör C, Jones JL, Hurst HC, Fitzgibbon J, Hart IR, Grose RP
(
2013
)
.
Functional analysis of a breast cancer-associated FGFR2 single nucleotide polymorphism using zinc finger mediated genome editing
.
PLoS One
vol.
8
,
(
11
)
Okosun J, Bödör C, Wang J, Araf S, Chelala C, Fitzgibbon J
(
2013
)
.
Genomic analysis reveals epigenetic ‘addiction’ underpinning follicular lymphoma and its transformation – a rationale for targeted epigenetic therapies
.
Clinical epigenetics
vol.
5
,
(
Suppl 1
)
S10
-
S10
.
Bouska A, McKeithan T, Deffenbacher KE, Lachel C, Wright GW, Iqbal J, Smith LM, Liu Z et al.
(
2012
)
.
Genetic Abnormalities in Follicular Lymphoma and Transformed Follicular Lymphoma
.
BLOOD
.
vol.
120
,
Böodöor C, Vera G, Kohlmann A, Tan K, Okosun J, Popov N, Araf S, Marzec J et al.
(
2012
)
.
High Incidence of EZH2 Mutations with Variable Mutation Load in Follicular Lymphoma and Its Consequences for EZH2 Targeted Therapy
.
Blood
vol.
120
,
(
21
)
545
-
545
.
Okosun J, Boedoer C, Wang J, Araf S, Marzec J, Iqbal S, Matthews J, Calaminici M et al.
(
2012
)
.
Whole Genome Sequencing in Sequential Biopsies Reveals the Genetic Evolution of Follicular Lymphoma to Transformed Follicular Lymphoma
.
BLOOD
.
vol.
120
,
Delage B, Luong P, Maharaj L, O'Riain C, Syed N, Crook T, Hatzimichael E, Papoudou-Bai A et al.
(
2012
)
.
Promoter methylation of argininosuccinate synthetase-1 sensitises lymphomas to arginine deiminase treatment, autophagy and caspase-dependent apoptosis
.
Cell Death Dis
vol.
3
,
Quintana-Bustamante O, Smith SL-L, Griessinger E, Reyal Y, Vargaftig J, Lister TA, Fitzgibbon J, Bonnet D
(
2012
)
.
Overexpression of wild-type or mutants forms of CEBPA alter normal human hematopoiesis
.
LEUKEMIA
vol.
26
,
(
7
)
1537
-
1546
.
Bödör C, Renneville A, Smith M, Charazac A, Iqbal S, Etancelin P, Cavenagh J, Barnett MJ et al.
(
2012
)
.
Germ-line GATA2 p.THR354MET mutation in familial myelodysplastic syndrome with acquired monosomy 7 and ASXL1 mutation demonstrating rapid onset and poor survival
.
Haematologica
vol.
97
,
(
6
)
890
-
894
.
Adams D, Altucci L, Antonarakis SE, Ballesteros J, Beck S, Bird A, Bock C, Boehm B et al.
(
2012
)
.
BLUEPRINT to decode the epigenetic signature written in blood
.
NATURE BIOTECHNOLOGY
vol.
30
,
(
3
)
224
-
226
.
Leich E, Zamo A, Horn H, Haralambieva E, Puppe B, Gascoyne RD, Chan W-C, Braziel RM et al.
(
2011
)
.
MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype
.
Blood
vol.
118
,
(
20
)
5550
-
5558
.
Okosun J, Fitzgibbon J
(
2011
)
.
It's a targeted world in non-Hodgkin's lymphoma
.
Br J Nurs
vol.
20
,
(
17
)
Okosun J, Fitzgibbon J
(
2011
)
.
It's a targeted world in non-Hodgkin's lymphoma
.
British Journal of Nursing
vol.
20
,
(
17 SUPPL.
)
Fitzgibbon J
(
2011
)
.
A Molecular Portrait of Follicular Lymphoma
.
EUROPEAN JOURNAL OF CANCER
.
vol.
47
,
S33
-
S33
.
Stevens J, Waters R, Sieniawska C, Kassam S, Montoto S, Fitzgibbon J, Rohatiner A, Lister A et al.
(
2011
)
.
Serum selenium concentration at diagnosis and outcome in patients with haematological malignancies
.
Br J Haematol
vol.
154
,
(
4
)
448
-
456
.
Montoto S, Fitzgibbon J
(
2011
)
.
Transformation of indolent B-cell lymphomas
.
J Clin Oncol
vol.
29
,
(
14
)
1827
-
1834
.
Szlosarek PW, Luong F, Clear A, Taussig D, Joel S, Calaminici M, Debernardi S, Fitzgibbon J et al.
(
2011
)
.
Abstract 4067: Pegylated arginine deiminase (ADI-PEG20) as a potential novel therapy for argininosuccinate synthetase-deficient acute myeloid leukemia
.
Cancer Research
vol.
71
,
(
8_Supplement
)
4067
-
4067
.
Szlosarek PW, Luong F, Clear A, Taussig D, Joel S, Calaminici M, Debernardi S, Fitzgibbon J et al.
(
2011
)
.
Pegylated arginine deiminase (ADI-PEG20) as a potential novel therapy for argininosuccinate synthetase-deficient acute myeloid leukemia
.
CANCER RESEARCH
vol.
71
,
Bödör C, O'Riain C, Wrench D, Matthews J, Iyengar S, Tayyib H, Calaminici M, Clear A et al.
(
2011
)
.
EZH2 Y641 mutations in follicular lymphoma
.
Leukemia
vol.
25
,
(
4
)
726
-
729
.
Wrench D, Leighton P, Skibola CF, Conde L, Cazier J-B, Matthews J, Iqbal S, Carlotti E et al.
(
2011
)
.
SNP rs6457327 in the HLA region on chromosome 6p is predictive of the transformation of follicular lymphoma
.
Blood
vol.
117
,
(
11
)
3147
-
3150
.
Langabeer SE, Owen CJ, McCarron SL, Fitzgibbon J, Smith OP, O'Marcaigh A, Browne P
(
2010
)
.
A novel RUNX1 mutation in a kindred with familial platelet disorder with propensity to acute myeloid leukaemia: male predominance of affected individuals
.
Eur J Haematol
vol.
85
,
(
6
)
552
-
553
.
Wrench D, Sangaralingam A, Tayyib H, Kang MK, Riain C, Gupta M, Carlotti E, Bodor C et al.
(
2010
)
.
TNFRSF14 and EZH2 Mutations, Chr2p Gain and Copy Number Changes Targeting Genes Whose Proteins Interact with the Microenvironment In Transformed Follicular Lymphoma
.
BLOOD
.
vol.
116
,
349
-
349
.
Wrench D, Montoto S, Fitzgibbon J
(
2010
)
.
Molecular signatures in the diagnosis and management of follicular lymphoma
.
Curr Opin Hematol
vol.
17
,
(
4
)
333
-
340
.
Ghazaly E, Smith P, Quentmeier H, Drexler H, Iqbal S, Taussig D, Young B, Lister A et al.
(
2010
)
.
ACCUMULATION OF 2-HYDROXYGLUTARATE (2-HG) IN NORMAL KARYOTYPE AML PATIENTS WITH IDH1 MUTATION
.
HAEMATOLOGICA
.
vol.
95
,
20
-
20
.
O'Riain C, Smith P, Clear A, Wrench D, Gupta M, Bodor C, Matolcsy A, Calaminici M et al.
(
2010
)
.
EZH2 MUTATION IN FOLLICULAR LYMPHOMA
.
HAEMATOLOGICA
.
vol.
95
,
167
-
167
.
Wrench J, Skibola C, Matthews J, Cazier JB, Iqbal S, Carlotti E, Calaminici M, Davies A et al.
(
2010
)
.
SNP RS6457327 ON CHROMOSOME 6P PREDICTS TRANSFORMATION OF FOLLICULAR LYMPHOMA
.
HAEMATOLOGICA
.
vol.
95
,
170
-
171
.
Ghazaly E, Smith P, Quentmeier H, Drexler H, Iqbal S, Taussig D, Young B, Lister A et al.
(
2010
)
.
ACCUMULATION OF 2-HYDROXYGLUTARATE (2-HG) IN NORMAL KARYOTYPE AML PATIENTS WITH IDH1 MUTATION
.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL
.
vol.
95
,
20
-
20
.
O' Riain C, Smith P, Clear A, Wrench D, Gupta M, Bodor C, Matolcsy A, Calaminici M et al.
(
2010
)
.
EZH2 MUTATION IN FOLLICULAR LYMPHOMA
.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL
.
vol.
95
,
167
-
167
.
Wrench J, Skibola C, Matthews J, Cazier JB, Iqbal S, Carlotti E, Calaminici M, Davies A et al.
(
2010
)
.
SNP RS6457327 ON CHROMOSOME 6P PREDICTS TRANSFORMATION OF FOLLICULAR LYMPHOMA
.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL
.
vol.
95
,
170
-
171
.
Szlosarek PW, Delage B, O'Riain C, Hatzimichael E, Crook T, Calaminici M, Gribben JG, Lemoine N et al.
(
2010
)
.
Effect of inactivation of argininosuccinate synthetase on sensitivity of lymphomas to caspase-dependent apoptosis following treatment with arginine deiminase
.
Journal of Clinical Oncology
vol.
28
,
(
15_suppl
)
8093
-
8093
.
Langabeer SE, Owen CJ, McCarron SL, Fitzgibbon J, O'Marcaigh A, Browne P
(
2010
)
.
A novel RUNX1 mutation in an Irish kindred with familial platelet disorder with propensity to acute myeloid leukaemia
.
BRITISH JOURNAL OF HAEMATOLOGY
.
vol.
149
,
73
-
73
.
Owen CJ, Fitzgibbon J
(
2010
)
.
The Genetics of Acute Myeloid Leukemias
.
Molecular Hematology: Third Edition
,
Owen C, Fitzgibbon J, Paschka P
(
2010
)
.
The clinical relevance of Wilms Tumour 1 (WT1) gene mutations in acute leukaemia
.
HEMATOL ONCOL
vol.
28
,
(
1
)
13
-
19
.
O'Riain C, Calaminici M, Clear A, Braziel RM, Gascoyne RD, Rosenwald A, Campo E, Smeland EB et al.
(
2010
)
.
DNA Methylation and Polycomb Repression in Follicular Lymphoma
.
MODERN PATHOLOGY
.
vol.
23
,
315A
-
315A
.
O'Riain C, O'Shea DM, Yang Y, Le Dieu R, Gribben JG, Summers K, Yeboah-Afari J, Bhaw-Rosun L et al.
(
2009
)
.
Array-based DNA methylation profiling in follicular lymphoma
.
Leukemia
vol.
23
,
(
10
)
1858
-
1866
.
Fitzgibbon J
(
2009
)
.
The Molecular Pathogenesis of Follicular Lymphoma
.
JOURNAL OF MEDICAL GENETICS
.
vol.
46
,
S24
-
S24
.
Leich E, Salaverria I, Bea S, Zettl A, Wright G, Moreno V, Gascoyne RD, Chan WC et al.
(
2009
)
.
Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations
.
BLOOD
vol.
114
,
(
4
)
826
-
834
.
Oke A, Pearce D, Wilkinson RW, Crafter C, Odedra R, Cavenagh J, Fitzgibbon J, Lister AT et al.
(
2009
)
.
AZD1152 Rapidly and Negatively Affects the Growth and Survival of Human Acute Myeloid Leukemia Cells In vitro and In vivo
.
CANCER RES
vol.
69
,
(
10
)
4150
-
4158
.
Carlotti E, Wrench D, Matthews J, Iqbal S, Davies A, Norton A, Hart J, Lai R et al.
(
2009
)
.
Transformation of follicular lymphoma to diffuse large B-cell lymphoma may occur by divergent evolution from a common progenitor cell or by direct evolution from the follicular lymphoma clone
.
Blood
vol.
113
,
(
15
)
3553
-
3557
.
O'Shea D, O'Riain C, Gupta M, Waters R, Yang Y, Wrench D, Gribben J, Rosenwald A et al.
(
2009
)
.
Regions of acquired uniparental disomy at diagnosis of follicular lymphoma are associated with both overall survival and risk of transformation
.
Blood
vol.
113
,
(
10
)
2298
-
2301
.
Fitzgibbon J, Gale R, Hills R, Virappane P, Burnett A, Lister TA, Linch D
(
2009
)
.
Comparing Apples and Oranges in Normal Karyotype Acute Myeloid Leukemia REPLY
.
J CLIN ONCOL
vol.
27
,
(
3
)
474
-
476
.
Wrench D, Waters R, Carlotti E, Iqbal S, Matthews J, Calaminici M, Gribben J, Lister TA et al.
(
2009
)
.
Clinical relevance of MDM2 SNP 309 and TP53 Arg72Pro in follicular lymphoma
.
HAEMATOL-HEMATOL J
vol.
94
,
(
1
)
148
-
150
.
Owen CJ, Toze CL, Koochin A, Forrest DL, Smith CA, Stevens JM, Jackson SC, Poon M-C et al.
(
2008
)
.
Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy
.
Blood
vol.
112
,
(
12
)
4639
-
4645
.
Virappane P, Gale R, Hills R, Kakkas I, Summers K, Stevens J, Allen C, Green C et al.
(
2008
)
.
Mutation of the Wilms' Tumor 1 Gene Is a Poor Prognostic Factor Associated With Chemotherapy Resistance in Normal Karyotype Acute Myeloid Leukemia: The United Kingdom Medical Research Council Adult Leukaemia Working Party
.
JOURNAL OF CLINICAL ONCOLOGY
.
vol.
26
,
5429
-
5435
.
Deffenbacher KE, Wright G, Iqbal J, Geng HM, O'Shea D, Lister TA, Fitzgibbon J, Fu K et al.
(
2008
)
.
Genetic Abnormalities Involved in the Development and Progression of Follicular Lymphoma
.
BLOOD
.
vol.
112
,
714
-
714
.
Deffenbacher KE, Wright G, Iqbal J, Geng H, O’Shea D, Lister TA, Fitzgibbon J, Fu K et al.
(
2008
)
.
Genetic Abnormalities Involved in the Development and Progression of Follicular Lymphoma
.
Blood
vol.
112
,
(
11
)
2049
-
2049
.
Yang YW, Wrench DJ, Lister TA, Fitzgibbon J
(
2008
)
.
Recurrent Chromosomal Intermingling Interactions at the BCL2 Locus in T(14;18) +Ve and -Ve Cell Lines
.
BLOOD
.
vol.
112
,
713
-
713
.
Yang Y, Wrench DJ, Lister TA, Fitzgibbon J
(
2008
)
.
Recurrent Chromosomal Intermingling Interactions at the BCL2 Locus in T(14;18) +Ve and −Ve Cell Lines
.
Blood
vol.
112
,
(
11
)
2048
-
2048
.
Quintana-Bustamante O, Smith SLL, Fitzgibbon J, Bonnet D
(
2008
)
.
Role of Different C/EBP alpha Mutations in AML Transformation
.
BLOOD
.
vol.
112
,
484
-
484
.
Quintana-Bustamante O, Smith SL-L, Fitzgibbon J, Bonnet D
(
2008
)
.
Role of Different C/EBPα Mutations in AML Transformation
.
Blood
vol.
112
,
(
11
)
1343
-
1343
.
O'Shea D, O'Riain C, Taylor C, Waters R, Carlotti E, Macdougall F, Gribben J, Rosenwald A et al.
(
2008
)
.
The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival
.
Blood
vol.
112
,
(
8
)
3126
-
3129
.
Raghavan M, Smith L-L, Lillington DM, Chaplin T, Kakkas I, Molloy G, Chelala C, Cazier J-B et al.
(
2008
)
.
Segmental uniparental disomy is a commonly acquired genetic event in relapsed acute myeloid leukemia
.
Blood
vol.
112
,
(
3
)
814
-
821
.
Stevens JM, Waters R, Sieniawska C, Rohatiner A, Fitzgibbon J, Joel SP, Lister TA
(
2008
)
.
ASSOCIATION OF SERUM SELENIUM AT PRESENTATION, PATIENT CHARACTERISTICS AND OUTCOME IN HODGKIN AND FOLLICULAR LYMPHOMA
.
HAEMATOLOGICA
.
vol.
93
,
249
-
249
.
Stevens JM, Juliger S, Summers K, Fitzgibbon J, Lister TA, Joel SP
(
2008
)
.
METHYLSELENINIC ACID DEMONSTRATES ANTI-LEUKAEMIC ACTIVITY AND SENSITISES AML CELLS TO THE EFFECTS OF CYTOTOXIC AGENTS BY INITIATING THE UNFOLDED PROTEIN RESPONSE
.
HAEMATOLOGICA
.
vol.
93
,
115
-
116
.
Wrench D, Waters R, Matthews J, Calaminici M, Carlotti E, Iqbal S, Gribben J, Lister A et al.
(
2008
)
.
MDM2 309 and TP53 ARG72PRO SNP genotypes do not predict clinical outcome of follicular lymphoma
.
ANNALS OF ONCOLOGY
.
vol.
19
,
178
-
178
.
Stevens JM, Juliger S, Summers K, Fitzgibbon J, Lister TA, Joel SP
(
2008
)
.
METHYLSELENINIC ACID DEMONSTRATES ANTI-LEUKAEMIC ACTIVITY AND SENSITISES AML CELLS TO THE EFFECTS OF CYTOTOXIC AGENTS BY INITIATING THE UNFOLDED PROTEIN RESPONSE
.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL
.
vol.
93
,
115
-
116
.
O'Riain C, O'Shea D, Yang Y, Gribben J, Afari J, Mein CA, Crook T, Smith P et al.
(
2008
)
.
Methylation profiling in 158 cases of previously untreated follicular lymphoma (FL)
.
ANNALS OF ONCOLOGY
.
vol.
19
,
101
-
101
.
O'Shea D, O'Riain C, MacDougall F, Gribben J, Young BD, Rosenwald A, Rimsza L, Roberts R et al.
(
2008
)
.
SNP array genotyping in 182 diagnostic follicular lymphoma cases identifies sites of AUPD associated with overall survival and risk of transformation
.
ANNALS OF ONCOLOGY
.
vol.
19
,
111
-
111
.
Owen C, Virappane P, Alikian M, Stasevich I, Summers K, Lillington D, Bonnet D, Burnett A et al.
(
2008
)
.
WTX is rarely mutated in acute myeloid leukemia
.
HAEMATOL-HEMATOL J
vol.
93
,
(
6
)
947
-
948
.
Owen CJ, Toze CJ, Forrest DL, Macheta A, Smith CA, Barnett MJ, Yin JAL, Lister TA et al.
(
2008
)
.
Should patients with myelodysplasia and/or acute myeloid leukemia (MDS/AML) be screened for inherited runx1 mutations prior to sibling donor allografting?
.
ANN HEMATOL
vol.
87
,
S11
-
S11
.
Owen C, Barnett M, Fitzgibbon J
(
2008
)
.
Familial myelodysplasia and acute myeloid leukaemia--a review
.
Br J Haematol
vol.
140
,
(
2
)
123
-
132
.
Carlotti E, Wrench D, Iqbal S, O’Shea D, Davies A, Virappane P, Hart J, Lai R et al.
(
2007
)
.
Determining the Mechanism of Transformation of Follicular Lymphoma into Diffuse Large B Cell Lymphoma
.
Blood
vol.
110
,
(
11
)
181
-
181
.
Carlotti E, Wrench D, Iqbal S, O'Shea D, Davies A, Virappane P, Hart J, Lai R et al.
(
2007
)
.
Determining the mechanism of transformation of follicular lymphoma into diffuse large B cell lymphoma
.
BLOOD
.
vol.
110
,
61A
-
61A
.
Virappane P, Gale RE, Hills R, Kakkas I, Summers K, Stevens J, Green C, Allen C et al.
(
2007
)
.
Mutation of the Wilms' tumor 1 gene is a poor prognostic factor associated with chemoresistance in normal karyotype acute myeloid leukemia
.
BLOOD
.
vol.
110
,
113A
-
113A
.
Virappane P, Gale RE, Hills R, Kakkas I, Summers K, Stevens J, Green C, Allen C et al.
(
2007
)
.
Mutation of the Wilms’ Tumor 1 Gene Is a Poor Prognostic Factor Associated with Chemoresistance in Normal Karyotype Acute Myeloid Leukemia
.
Blood
vol.
110
,
(
11
)
361
-
361
.
Owen CJ, Yin JAL, Toze CJ, Forrest DL, Macheta A, Smith CA, Barnett MJ, Lister TA et al.
(
2007
)
.
Should patients with myelodysplasia and/or acute myeloid leukemia (MDS/AML) be screened for inherited RUNX1 mutations prior to sibling donor allografting?
.
BLOOD
.
vol.
110
,
336B
-
336B
.
Jüliger S, Goenaga-Infante H, Lister TA, Fitzgibbon J, Joel SP
(
2007
)
.
Chemosensitization of B-cell lymphomas by methylseleninic acid involves nuclear factor-kappaB inhibition and the rapid generation of other selenium species
.
Cancer Res
vol.
67
,
(
22
)
10984
-
10992
.
Fitzgibbon J, Iqbal S, Davies A, O'shea D, Carlotti E, Chaplin T, Matthews J, Raghavan M et al.
(
2007
)
.
Genome-wide detection of recurring sites of uniparental disomy in follicular and transformed follicular lymphoma
.
Leukemia
vol.
21
,
(
7
)
1514
-
1520
.
Owen C, Stevens J, Amess J, Chaplin T, Cavenagh J, Lillington D, Young BD, Lister TA et al.
(
2007
)
.
Familial myelodysplasia with monosomy 7
.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL
.
vol.
92
,
234
-
234
.
O'Shea D, Iqbal S, Carlotti E, Davies A, Chaplin T, Matthews J, Manoj M, Norton A et al.
(
2007
)
.
SNP array profiling of follicular lymphoma reveals novel regions of acquired UPD
.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL
.
vol.
92
,
62
-
62
.
Kakkas I, Summers K, Fleischmann C, Virappane P, Lister TA, Fitzgibbon J
(
2007
)
.
Simultaneous detection of FLT3, NPM1 and WT1 mutations using high-resolution capillary electrophoresis
.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL
.
vol.
92
,
370
-
370
.
Virappane P, Gale RE, Hills RK, Kakkas K, Summers K, Stevens J, Green CL, Allen CG et al.
(
2007
)
.
Wilms' tumour 1 mutation in normal karyotype aml
.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL
.
vol.
92
,
19
-
20
.
Raghavan M, Smith LL, Chaplin T, Lillington D, Molloy G, Kakkas I, Chelala C, Cazier JB et al.
(
2007
)
.
Frequent relapse of acute myeloid leukaemia by mitotic recombination
.
BRITISH JOURNAL OF HAEMATOLOGY
.
vol.
137
,
25
-
25
.
Juliger S, Joel SP, Fitzgibbon J, Lister TA
(
2007
)
.
Serum selenium at presentation may predict disease outcome in acute myeloid leukaemia (AML)
.
BRITISH JOURNAL OF HAEMATOLOGY
.
vol.
137
,
65
-
65
.
Davies AJ, Rosenwald A, Wright G, Lee A, Last KW, Weisenburger DD, Chan WC, Delabie J et al.
(
2007
)
.
Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms
.
BRIT J HAEMATOL
vol.
136
,
(
2
)
286
-
293
.
Summers K, Stevens J, Kakkas I, Smith M, Smith LL, MacDougall F, Cavenagh J, Bonnet D et al.
(
2007
)
.
Wilms' tumour 1 mutations are associated with FLT3-ITD and failure of standard induction chemotherapy in patients with normal karyotype AML [1]
.
Leukemia
vol.
21
,
(
3
)
550
-
551
.
O'Shea D, Iqbal S, Carlotti E, Davies A, Chaplin T, Matthews J, Raghavan M, Norton A et al.
(
2006
)
.
aUPD in the clonal evolution of follicular lymphoma
.
BLOOD
.
vol.
108
,
585A
-
585A
.
Last K, Maharaj L, Perry J, Strauss S, Fitzgibbon J, Lister TA, Joel S
(
2006
)
.
The activity of methylated and non-methylated selenium species in lymphoma cell lines and primary tumours
.
ANN ONCOL
vol.
17
,
(
5
)
773
-
779
.
Zhang LY, Smith ML, Schultheis B, Fitzgibbon J, Lister TA, Melo JV, Cross NCP, Cavenagh JD
(
2006
)
.
A novel K5091 mutation of KIT identified in familial mastocytosis - in vitro and in vivo responsiveness to imatinib therapy
.
LEUKEMIA RES
vol.
30
,
(
4
)
373
-
378
.
Smith LL, Pearce D, Smith ML, Jenner M, Lister TA, Bonnet D, Goff L, Fitzgibbon J
(
2006
)
.
Development of a quantitative real-time polymerase chain reaction method for monitoring CEBPA mutations in normal karyotype acute myeloid leukaemia
.
BRIT J HAEMATOL
vol.
133
,
(
1
)
103
-
105
.
Juliger S, Goenaga-Infante H, Fitzgibbon J, Lister AT, Joel SP
(
2005
)
.
Methylseleninic Acid Results in Rapid Changes in Intracellular Selenium Species and Sensitises Human Lymphoma Cells to Doxorubicin
.
Blood
vol.
106
,
(
11
)
1768
-
1768
.
Juliger S, Goenaga-Infante H, Fitzgibbon J, Lister AT, Joel SP
(
2005
)
.
Methylseleninic acid results in rapid changes in intracellular selenium species and sensitises human lymphoma cells to doxorubicin
.
BLOOD
.
vol.
106
,
503A
-
503A
.
Joel SP, Oke A, Foot N, Keen N, Bonnet D, Lister TA, Fitzgibbon J
(
2005
)
.
The activity of the novel aurora kinase B inhibitor AZD1152 in acute myeloid leukaemia cells
.
BLOOD
.
vol.
106
,
943A
-
943A
.
Fitzgibbon J, Smith L-L, Raghavan M, Smith ML, Debernardi S, Skoulakis S, Lillington D, Lister TA et al.
(
2005
)
.
Association between acquired uniparental disomy and homozygous gene mutation in acute myeloid leukemias
.
Cancer Res
vol.
65
,
(
20
)
9152
-
9154
.
Davies AJ, Lee AM, Taylor C, Clear AJ, Goff LK, Iqbal S, Cuthbert-Heavens D, Calaminici M et al.
(
2005
)
.
A limited role for TP53 mutation in the transformation of follicular lymphoma to diffuse large B-cell lymphoma
.
LEUKEMIA
vol.
19
,
(
8
)
1459
-
1465
.
Smith LL, Smith M, Goff L, Jenner M, Lister A, Fitzgibbon J, Bonnett D
(
2005
)
.
Development of a quantitative real-time PCR method for monitoring CEBPA mutations in normal karyotype acute myeloid leukaemia patient samples
.
EXPERIMENTAL HEMATOLOGY
.
vol.
33
,
73
-
73
.
Davies A, Iqbal S, Fitzgibbon J, Raghavan M, Chaplin T, Norton A, Lister A, Young B
(
2005
)
.
Homozygosity mapping by genome-wide SNP analysis of the transformation of follicular lymphoma (FL) to diffuse large B-cell lymphoma (TxDLBCL)
.
ANNALS OF ONCOLOGY
.
vol.
16
,
106
-
106
.
Davies A, Arch R, Goff L, Gesk S, Foot N, Rosenwald A, Dyer M, Marinez-Climent J et al.
(
2005
)
.
Refinement of the 13q31-32 amplicon in B-cell non-Hodgkin's lymphoma by a simultaneous genomic and transcriptional approach
.
ANNALS OF ONCOLOGY
.
vol.
16
,
80
-
80
.
Suraweera N, Meijne E, Moody J, Carvajal-Carmona LG, Yoshida K, Pollard P, Fitzgibbon J, Riches A et al.
(
2005
)
.
Mutations of the PU.1 Ets domain are specifically associated with murine radiation-induced, but not human therapy-related, acute myeloid leukaemia
.
Oncogene
vol.
24
,
(
22
)
3678
-
3683
.
Lee A, Davies AJ, Clear A, Calaminici M, Matthews J, Norton A, Wright G, Staudt MLM et al.
(
2005
)
.
Tissue microarray is a useful tool in the evaluation of genes implicated in transformation of follicular lymphoma
.
JOURNAL OF PATHOLOGY
.
vol.
205
,
11
-
11
.
Smith ML, Arch R, Smith L-L, Bainton N, Neat M, Taylor C, Bonnet D, Cavenagh JD et al.
(
2005
)
.
Development of a human acute myeloid leukaemia screening panel and consequent identification of novel gene mutation in FLT3 and CCND3
.
Br J Haematol
vol.
128
,
(
3
)
318
-
323
.
Smith ML, Cavenagh JD, Lister TA, Fitzgibbon J
(
2004
)
.
Brief report - Mutation of CEBPA in familial acute myeloid leukemia
.
NEW ENGL J MED
vol.
351
,
(
23
)
2403
-
2407
.
Smith ML, Cavenagh JD, Lister TA, Fitzgibbon J
(
2004
)
.
Mutation of CEBPA in familial acute myeloid leukemia
.
N Engl J Med
vol.
351
,
(
23
)
2403
-
2407
.
Beguin Y, Weber G, Last KW, Rohatiner AZS, Fitzgibbon J, Lister TA
(
2004
)
.
Serum selenium in lymphoma [1] (multiple letters)
.
Journal of Clinical Oncology
vol.
22
,
(
16
)
3429
-
3430
.
Fitzgibbon J, Smith M, Arch R, Smith L-L, Bainton N, Neat M, Bonnet D, Cavenagh J et al.
(
2004
)
.
Development of a Human Acute Myeloid Leukaemia Screening Panel and Identification of Novel Gene Mutations
.
Blood
vol.
104
,
(
11
)
2991
-
2991
.
Fitzgibbon J, Smith M, Arch R, Smith LL, Bainton N, Neat M, Bonnet D, Cavenagh J et al.
(
2004
)
.
Development of a human acute myeloid leukaemia screening panel and identification of novel gene mutations
.
BLOOD
.
vol.
104
,
817A
-
817A
.
Ridler C, Smith M, Milne T, Ebrahim F, Macey M, Lister TA, Fitzgibbon J, Cavenagh JD et al.
(
2004
)
.
Flow cytometric FLT3 expression in acute leukaemias is of diagnostic value but does not correlate with ITD/D835Y mutation status
.
BLOOD
.
vol.
104
,
823A
-
823A
.
Fitzgibbon J, Smith M, Cavenagh J, Lister TA
(
2004
)
.
Mutation of CEBPA in familial acute myeloid leukaemia
.
BLOOD
.
vol.
104
,
555A
-
555A
.
Davies AJ, Lee AM, Taylor C, Clear AJ, Goff LK, Iqbal S, Cuthbert-Heavens D, Calaminici M et al.
(
2004
)
.
Sequential Time-Point Mutational Analysis of TP53 in Follicular Lymphoma Undergoing Transformation to Large B-Cell Lymphoma
.
Blood
vol.
104
,
(
11
)
1361
-
1361
.
Davies AJ, Lee AM, Taylor C, Clear AJ, Goff LK, Iqbal S, Cuthbert-Heavens D, Calaminici M et al.
(
2004
)
.
Sequential time-point mutational analysis of TP53 in follicular lymphoma undergoing transformation to large B-cell lymphoma
.
BLOOD
.
vol.
104
,
382A
-
382A
.
Last K, Perry J, Maharaj L, Strauss S, Davies A, Skoulakis S, Fitzgibbon J, Lister A et al.
(
2004
)
.
The induction of apoptosis in lymphoma cells by methylseleninic acid and selenodiglutathione
.
BLOOD
.
vol.
104
,
686A
-
686A
.
Lee A, Davies A, Clear A, Calaminici M, Matthews J, Norton A, Wright G, Staudt LM et al.
(
2004
)
.
Tissue microarray is a useful tool in the evaluation of genes implicated in transformation of follicular lymphoma
.
BLOOD
.
vol.
104
,
624A
-
624A
.
Last KW, Rohatiner AZS, Fitzgibbon J, Lister TA
(
2004
)
.
Serum selenium in lymphoma - In reply
.
J CLIN ONCOL
vol.
22
,
(
16
)
3430
-
3430
.
Nilsen H, An Q, Fitzgibbon J, Lister A, Lindahl T
(
2004
)
.
Complex phenotypes associated with uracil in DNA in mammals
.
BRITISH JOURNAL OF CANCER
.
vol.
91
,
S71
-
S71
.
Iqbal S, Jenner MJR, Summers KE, Davies AJ, Matthews J, Norton AJ, Calaminici M, Rohatiner AZ et al.
(
2004
)
.
Reliable detection of clonal IgH/Bcl2 MBR rearrangement in follicular lymphoma: methodology and clinical significance
.
Br J Haematol
vol.
124
,
(
3
)
325
-
328
.
Goff LK, Iqbal S, Jenner MJ, Summers KE, Matthews J, Norton AJ, Calaminici M, Rohatiner AZS et al.
(
2003
)
.
Reliable detection of clonal IgH/Bcl-2 MBR rearrangement in follicular lymphoma: Methodology and clinical significance
.
BLOOD
.
vol.
102
,
633A
-
633A
.
Debernardi S, Van Delft F, Davies A, Lillington D, Smith M, Lister TA, Saha V, Young BD et al.
(
2003
)
.
The Wiskott-Aldrich-Syndrome family member 1 (WASF1) gene on 6q21 is down-regulated in specific AML cytogenetic subtypes
.
BLOOD
.
vol.
102
,
582A
-
582A
.
Last KW, Cornelius V, Delves T, Sieniawska C, Fitzgibbon J, Norton A, Amess J, Wilson A et al.
(
2003
)
.
Presentation serum selenium predicts for overall survival, dose delivery, and first treatment response in aggressive non-Hodgkin's lymphoma
.
J Clin Oncol
vol.
21
,
(
12
)
2335
-
2341
.
Snaddon J, Smith ML, Neat M, Cambal-Parrales M, Dixon-McIver A, Arch R, Amess JA, Rohatiner AZ et al.
(
2003
)
.
Mutations of CEBPA in acute myeloid leukemia FAB types M1 and M2
.
Genes Chromosomes Cancer
vol.
37
,
(
1
)
72
-
78
.
Smith ML, Snaddon J, Neat M, Cambal-Parrales M, Arch R, Lister TA, Fitzgibbon J
(
2003
)
.
Mutation of BRAF is uncommon in AML FAB type M1 and M2
.
LEUKEMIA
vol.
17
,
(
1
)
274
-
275
.
Davies A, Rosenwald A, Wright G, Henrickson SE, Hong Z, Fitzgibbon J, Last K, Norton A et al.
(
2002
)
.
Gene expression profiling in paired follicular lymphoma samples pre- and post-transformation to large B cell lymphoma
.
BLOOD
.
vol.
100
,
315A
-
316A
.
Jenner M, Summers K, Matthews J, Bradburn M, Dunning A, Wilson G, Lister TA, Fitzgibbon J
(
2002
)
.
Genetic risk factor for follicular lymphoma within the MHC region
.
BLOOD
.
vol.
100
,
567A
-
567A
.
Fitzgibbon J, Arch R, Davies A, Snaddon J, Neat M, Foot N, Summers K, Goff L et al.
(
2002
)
.
Refinement and evaluation of candidate genes within the 13q amplicon in germinal centre lymphoma
.
BLOOD
.
vol.
100
,
189B
-
190B
.
Jenner MJ, Summers KE, Norton AJ, Amess JA, Arch RS, Young BD, Lister TA, Fitzgibbon J et al.
(
2002
)
.
JH probe real-time quantitative polymerase chain reaction assay for Bcl-2/IgH rearrangements
.
Br J Haematol
vol.
118
,
(
2
)
550
-
558
.
Summers KE, Davies AJ, Matthews J, Jenner MJ, Cornelius V, Amess JA, Norton AJ, Rohatiner AZS et al.
(
2002
)
.
The relative role of peripheral blood and bone marrow for monitoring molecular evidence of disease in follicular lymphoma by quantitative real-time polymerase chain reaction
.
Br J Haematol
vol.
118
,
(
2
)
563
-
566
.
Snaddon J, Neat M, Fitzgibbon J, Smith ML, Rohatiner AZ, Lister TA, Amess JA
(
2002
)
.
Mutations in the runt homology domain of CBFalpha2 in myeloid malignancies with acquired trisomy 21
.
Cancer Genet Cytogenet
vol.
136
,
(
2
)
151
-
152
.
Summers KE, Goff LK, Wilson AG, Gupta RK, Lister TA, Fitzgibbon J
(
2001
)
.
The frequency of the Bcl-2/IgH t(14;18)(q32;q21) rearrangement in normal individuals implications for the monitoring of disease in patients with follicular lymphoma
.
LEUKEMIA
vol.
15
,
(
12
)
2024
-
2024
.
Jenner MJ, Summers KE, Norton AJ, Amess JA, Arch RS, Young BD, Lister TA, Fitzgibbon J et al.
(
2001
)
.
A universal strategy for quantifying Bcl-2/IgH breakpoints in follicular lymphoma
.
BLOOD
vol.
98
,
(
11
)
126A
-
126A
.
Snaddon J, Arch R, Sutcliffe K, Lister TA, Fitzgibbon J
(
2001
)
.
Identification of several novel polymorphisms in the low affinity FC inhibitory receptor FCGR2B
.
BLOOD
vol.
98
,
(
11
)
164B
-
164B
.
Snaddon J, Neat M, Smith ML, Rohatiner AZ, Lister TA, Fitzgibbon J
(
2001
)
.
Mutations in the runt domain of CBFA2 in myeloid malignancies with acquired trisomy 21
.
BLOOD
vol.
98
,
(
11
)
195B
-
195B
.
Snaddon J, Smith ML, Neat M, Arch R, Cambal-Parrales M, Amess JA, Rohatiner AZ, Lister TA et al.
(
2001
)
.
Mutations of CEBPA in acute myeloid leukaemia FAB-type M1 and M2
.
BLOOD
vol.
98
,
(
11
)
195B
-
195B
.
Davies AJ, Summers KE, Matthews J, Jenner MJ, Amess JA, Norton AJ, Rohatiner AZ, Fitzgibbon J et al.
(
2001
)
.
The relative role of peripheral blood and bone marrow for monitoring molecular evidence of disease in follicular lymphoma by quantitative real time PCR
.
BLOOD
vol.
98
,
(
11
)
124A
-
125A
.
Neat MJ, Foot N, Jenner M, Goff L, Ashcroft K, Burford D, Dunham A, Norton A et al.
(
2001
)
.
Localisation of a novel region of recurrent amplification in, follicular lymphoma to an similar to 6.8 Mb region of 13q32-33
.
GENE CHROMOSOME CANC
vol.
32
,
(
3
)
236
-
243
.
Foot N, Neat M, Jenner M, Goff L, Dunham I, Ross M, Fitzgibbon J, Lister TA
(
2001
)
.
Localisation of a novel region of amplification in follicular lymphoma tumours to a 24cR region of human chromosome 13
.
J MED GENET
vol.
38
,
S44
-
S44
.
Last KW, Cornelius V, Delves T, Fitzgibbon J, Wilson A, Rohatiner AZS, Lister TA
(
2001
)
.
Presentation serum selenium predicts for overall survival in patients with diffuse large B-cell (DLBC) lymphoma
.
BRIT J CANCER
vol.
85
,
59
-
59
.
Summers KE, Goff LK, Wilson AG, Gupta RK, Lister TA, Fitzgibbon J
(
2001
)
.
Frequency of the Bcl-2/IgH rearrangement in normal individuals: implications for the monitoring of disease in patients with follicular lymphoma
.
J Clin Oncol
vol.
19
,
(
2
)
420
-
424
.
Fitzgibbon J, Hill AS, Arch RS
(
2000
)
.
Identification of a novel polymorphism in the human FCGR2B gene: Correlation with response to rituximab treatment in patients with follicular lymphoma
.
Blood
vol.
96
,
(
11 PART II
)
Jenner MJ, Matthews J, Summers K, Young BD, Fitzgibbon J, Lister A
(
2000
)
.
Application of real time PCR to establishing clonality of Bcl-2 rearrangements in patients with follicular lymphoma
.
BLOOD
vol.
96
,
(
11
)
332A
-
332A
.
Fitzgibbon J, Hill AS, Arch RS, Sutcliffe C, Summers KE, Lister A
(
2000
)
.
Identification of a novel polymorphism in the human FCGR2B gene: Correlation with response to Rituximab treatment in patients with follicular lymphoma
.
BLOOD
vol.
96
,
(
11
)
179B
-
179B
.
Neat M, Foot N, Jenner M, Goff L, Ashcroft K, Burford D, Dunham A, Fitzgibbon J et al.
(
2000
)
.
Localisation of a novel region of amplification in follicular lymphoma to an similar to 6.8 Mb region of human chromosome 13q32-33
.
BLOOD
vol.
96
,
(
11
)
87A
-
87A
.
Last KW, Cornelius VR, Delves T, Fitzgibbon J, Wilson A, Rohatiner AZ, Lister A
(
2000
)
.
Presentation serum selenium predicts for overall survival in patients with diffuse large B-cell (DLBC) lymphoma
.
BLOOD
vol.
96
,
(
11
)
335A
-
335A
.
Last KW, Goff LK, Summers KE, Neat M, Jenner M, Crawley C, Rohatiner AZ, Fitzgibbon J et al.
(
2000
)
.
Familial follicular lymphoma: A case report with molecular analysis [2]
.
British Journal of Haematology
vol.
110
,
(
3
)
744
-
745
.
Fitzgibbon J, Neat MJ, Jones L, Foot N, Lister TA, Gupta RK
(
2000
)
.
Assignment of B-cell lymphoma 6, member B (zinc finger protein) gene (BCL6B) to human chromosome 17p13.1 by in situ hybridization
.
Cytogenetics and Cell Genetics
vol.
89
,
(
3-4
)
218
-
219
.
Fitzgibbon J, Neat MJ, Foot N, Hill AS, Lister TA, Gupta RK
(
2000
)
.
Assignment of brain acid-soluble protein 1 (BASP1) to human chromosome 5p15.1· p14, differential expression in human cancer cell lines as a result of alterations in gene dosage
.
Cytogenetics and Cell Genetics
vol.
89
,
(
3-4
)
147
-
149
.
Fitzgibbon J, Grenzelias D, Matthews J, Andrew Lister T, Gupta RK
(
1999
)
.
Tumour necrosis factor polymorphisms and susceptibility to follicular lymphoma
.
British Journal of Haematology
vol.
107
,
(
2
)
388
-
391
.
Halford S, Dulai KS, Daw SC, Fitzgibbon J, Hunt DM
(
1998
)
.
Isolation and chromosomal localization of two human CDP-diacylglycerol synthase (CDS) genes
.
Genomics
vol.
54
,
(
1
)
140
-
144
.
Hunt DM, Fitzgibbon J, Slobodyanyuk SJ, Bowmaker JK, Dulai KS
(
1997
)
.
Molecular Evolution of the Cottoid Fish Endemic to Lake Baikal Deduced from Nuclear DNA Evidence
.
Molecular Phylogenetics and Evolution
vol.
8
,
(
3
)
415
-
422
.
Katsanis N, Fitzgibbon J, Fisher EMC
(
1996
)
.
Paralogy mapping: Identification of a region in the human MHC triplicated onto human chromosomes 1 and 9 allows the prediction and isolation of novel PBX and NOTCH loci
.
Genomics
vol.
35
,
(
1
)
101
-
108
.
Fitzgibbon J, Katsanis N, Wells D, Delhanty J, Vallins W, Hunt DM
(
1996
)
.
Human guanylate kinase (GUK1): cDNA sequence, expression and chromosomal localisation
.
FEBS Letters
vol.
385
,
(
3
)
185
-
188
.
Hunt DM, Fitzgibbon J, Slobodyanyuk SJ, Bowmaker JK
(
1996
)
.
Spectral tuning and molecular evolution of rod visual pigments in the species flock of cottoid fish in Lake Baikal
.
Vision Research
vol.
36
,
(
9
)
1217
-
1224
.
Fitzgibbon J, Hope A, Slobodyanyuk SJ, Bellingham J, Bowmaker JK, Hunt DM
(
1995
)
.
The rhodopsin-encoding gene of bony fish lacks introns
.
Gene
vol.
164
,
(
2
)
273
-
277
.
Woodward K, Nahmias J, Hornigold N, West L, Pilz A, Benham F, Kwiatkowski D, Fitzgibbon J et al.
(
1995
)
.
Regional localization of 64 cosmid contigs, including 18 genes and 14 markers, to intervals on human chromosome 9q34
.
Genomics
vol.
29
,
(
1
)
257
-
260
.
Pilz A, Schaap D, Hunt D, Fitzgibbon J
(
1995
)
.
Chromosomal localization of three mouse diacylglycerol kinase (DAGK) genes: genes sharing sequence homology to the Drosophila retinal degeneration A (rdgA) gene
.
Genomics
vol.
26
,
(
3
)
599
-
601
.
Nahmias J, Hornigold N, Fitzgibbon J, Woodward K, Pilz A, Griffin D, Henske EP, Nakamura Y et al.
(
1995
)
.
Cosmid contigs spanning 9q34 including the candidate region for TSC1
.
European Journal of Human Genetics
vol.
3
,
(
2
)
65
-
77
.
Fitzgibbon J, Wells D, Pilz A, Delhanty J, Kai M, Kanoh H, Hunt D
(
1995
)
.
Localisation of the gene encoding diacylglycerol kinase 3 (DAGK3) to human chromosome 3q27-28 and mouse chromosome 16
.
Current Eye Research
vol.
14
,
(
11
)
1041
-
1043
.
Fitzgibbon J, Appukuttan B, Gayther S, Wells D, Delhanty J, Hunt DM
(
1994
)
.
Localisation of the human blue cone pigment gene to chromosome band 7q31.3-32
.
Human Genetics
vol.
93
,
(
1
)
79
-
80
.
Fitzgibbon J, Pilz A, Gayther S, Appukuttan B, Dulai KS, Delhanty JDA, Helmkamp GM, Yarbrough LR et al.
(
1994
)
.
Localization of the gene encoding human phosphatidylinositol transfer protein (PITPIM) to 17p13.3: A gene showing homology to the Drosophila retinal degeneration B gene (rdgB)
.
Cytogenetic and Genome Research
vol.
67
,
(
3
)
205
-
207
.
JONES KA, FITZGIBBON J, WOODWARD KJ, GOUDIE D, FERGUSON‐SMITH MA, POVEY S, WOLFE J, SOLOMON E
(
1993
)
.
Localization of the retinoid X receptor alpha gene (RXRA) to chromosome 9q34
.
Annals of Human Genetics
vol.
57
,
(
3
)
195
-
201
.
FITZGIBBON J, GILLETT GT, WOODWARD KJ, BOYLE JM, WOLFE J, POVEY S
(
1993
)
.
Mapping of RXRB to human chromosome 6p21. 3
.
Annals of Human Genetics
vol.
57
,
(
3
)
203
-
209
.
Degen SJF, Schaefer LA, Jamison CS, Grant SG, Fitzgibbon JJ, Pai JA, Chapman VM, Elliott RW
(
1990
)
.
Characterization of the cDNA Coding for Mouse Prothrombin and Localization of the Gene on Mouse Chromosome 2
.
DNA and Cell Biology
vol.
9
,
(
7
)
487
-
498
.